Characteristics, disease burden, and preliminary outcomes of patients with myasthenia gravis in real-world treatment settings across the United States

被引：0
|
作者：
Tierney, Meghan [1 ]
Chen, Joy [1 ]
Taylor, Sara Snell [1 ]
Cibelli, Emily [1 ]
机构：
[1] PicnicHealth, San Francisco, CA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
318
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [1] CHARACTERISTICS AND TREATMENT PATTERNS OF A UNITED STATES GENERALIZED MYASTHENIA GRAVIS POPULATION: INTERIM ANALYSIS OF REAL-WORLD DATA
    Miller-Wilson, Lesley-Ann
    Conyers, Joe
    Birija, Shiva Lauretta
    Ringland, Ciara
    Gibson, Gregor
    Hatchell, Niall
    Edwards, Yuriy
    MUSCLE & NERVE, 2024, 70 (03) : 637 - 637
  • [2] Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States
    Phillips, Glenn
    Abreu, Catarina
    Goyal, Amit
    Li, Yuebing
    Whangbo, Albert
    Gelinas, Deborah
    Brauer, Edward
    Bhattacharya, Sankha
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [3] REAL-WORLD TREATMENT PATTERNS IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS INITIATING INTRAVENOUS IMMUNOGLOBULIN IN THE UNITED STATES
    Hughes, Tom
    Qi, Cynthia
    Gelinas, Deborah
    Li, Yuebing
    Goyal, Amit
    Brauer, Edward
    Bhuwalka, Arpit
    Sato, Mai
    Jadhav, Sudhir
    Phillips, Glenn
    MUSCLE & NERVE, 2022, 66 : S123 - S123
  • [4] REAL-WORLD USAGE PATTERNS AND COSTS OF IVIG TREATMENT IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS IN THE UNITED STATES
    Qi, C.
    Hughes, T.
    Li, Y.
    Gelinas, D.
    Goyal, A.
    Bhuwalka, A.
    Sato, M.
    Jadhav, S.
    Phillips, G.
    VALUE IN HEALTH, 2022, 25 (07) : S494 - S495
  • [5] REAL-WORLD CLINICAL CHARACTERISTICS AND DISEASE MANAGEMENT OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS ACROSS THE UNITED STATES
    Abner, S.
    Bissell, M. C. S.
    Polakow, T.
    Baker, M. D.
    VALUE IN HEALTH, 2024, 27 (06) : S194 - S194
  • [6] Physician-Reported Perspectives on Myasthenia Gravis in the United States: A Real-World Survey
    Milada Mahic
    Ali M. Bozorg
    Jonathan J. DeCourcy
    Keisha J. Golden
    Gregor A. Gibson
    Christian F. Taylor
    Angela Ting
    Tyler J. Story
    Anna Scowcroft
    Neurology and Therapy, 2022, 11 : 1535 - 1551
  • [7] REAL-WORLD TREATMENT PATHWAYS AMONG ADULT PATIENTS WITH MYASTHENIA GRAVIS
    Bohn, J.
    Jacobson, M. H.
    Conover, M.
    Kern, D. M.
    VALUE IN HEALTH, 2023, 26 (06) : S242 - S242
  • [8] Physician-Reported Perspectives on Myasthenia Gravis in the United States: A Real-World Survey
    Mahic, Milada
    Bozorg, Ali M.
    DeCourcy, Jonathan J.
    Golden, Keisha J.
    Gibson, Gregor A.
    Taylor, Christian F.
    Ting, Angela
    Story, Tyler J.
    Scowcroft, Anna
    NEUROLOGY AND THERAPY, 2022, 11 (04) : 1535 - 1551
  • [9] Real-World experience with efgartigimod in patients with myasthenia gravis
    Fuchs, Lior
    Shelly, Shahar
    Vigiser, Ifat
    Kolb, Hadar
    Regev, Keren
    Schwartzmann, Yoel
    Vaknin-Dembinsky, Adi
    Dori, Amir
    Karni, Arnon
    JOURNAL OF NEUROLOGY, 2024, 271 (06) : 3462 - 3470
  • [10] DISEASE BURDEN, TREATMENT LANDSCAPE, AND HEALTH RELATED QUALITY OF LIFE OUTCOMES IN MYASTHENIA GRAVIS: RESULTS FROM THE ADELPHI REAL WORLD DISEASE SPECIFIC PROGRAMME IN THE UNITED STATES AND EUROPE
    Gray, C.
    Greene, N.
    De Courcy, J.
    Shor, S.
    Anson, L.
    Gibson, G.
    VALUE IN HEALTH, 2023, 26 (06) : S196 - S196
12345